Name: Transluminal Coronary Angioplasty and Intracoronary Thrombolysis: Coronary Heart Disease iv (en Inglés)
Price: 302455.00 COP
Availability: InStock
Author: kaltenbach, m.
ISBN: 9783642683602

portada Transluminal Coronary Angioplasty and Intracoronary Thrombolysis: Coronary Heart Disease iv (en Inglés)

Formato

Libro Físico

Editorial

Springer

Autor

kaltenbach, m.

Año

2011

Idioma

Inglés

N° páginas

464

Encuadernación

Tapa Blanda

ISBN

3642683606

ISBN13

9783642683602

Categorías

Enfermedades cardiovasculares

Transluminal Coronary Angioplasty and Intracoronary Thrombolysis: Coronary Heart Disease iv (en Inglés)

Kaltenbach, M. (Autor) · Springer · Tapa Blanda

Libro Nuevo

$ 302.455

$ 465.316

Ahorras: $ 162.860

35% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 24 de Mayo y el Jueves 30 de Mayo.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Transluminal Coronary Angioplasty and Intracoronary Thrombolysis: Coronary Heart Disease iv (en Inglés)"

This volume contains the proceedings of the Fourth International Symposium on Coronary Heart Disease, held in Frankfurt/Federal Republic of Germany. In 1970, when the fIrst symposium was held, the whole range of diagnostic and therapeutic measures was covered, but since then interest in coronary heart disease has increased so considerably that the fourth symposium was restricted to only two therapeutic aspects, angioplasty and intracoronary thrombolysis. It can be noted with pleasure that European cardiologists, namely Andreas Griintzig and Peter Rentrop, have made essential contributions to the applicability of these modes of treatment. When angioplasty was fIrst discussed at the Third International Symposium (Coronary Heart Disease, Stuttgart, 1978) a great deal of astonishment was expressed. Today the procedure has gained an important place in the treatment of angina pecto ris. The proportion of candidates for coronary surgery in whom angioplasty can be attempted instead of operation is around 10%, in certain subgroups even higher. The most remarkable fmding of our 5-year experience with angioplasty are the extre mely good long-term results. Recurrences happen in about 15%-20% of cases within the fIrst 3 months; after this period of time, recurrences are very unusual and mostly due to progression of the disease at other sites. Angioplasty has thus also contributed to our understanding of the dynamics of the atherosclerotic process.